Merck & Company (MRK) stock is experiencing a surge today after the company announced it has finalized negotiations with the pan-Canadian Pharmaceutical Alliance for its drug WELIREG. This agreement paves the way for WELIREG to be publicly reimbursed in Canada, a significant step forward for the drug’s accessibility in the country.